These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 699537)

  • 1. Studies on maxindol as an amine uptake inhibitor.
    Fuller RW; Snoddy HD; Wong DT; Bymaster FP
    Commun Psychopharmacol; 1978; 2(3):223-30. PubMed ID: 699537
    [No Abstract]   [Full Text] [Related]  

  • 2. Some effects of mazindol on the metabolism of monoamines in the rat brain [proceedings].
    Charlton KG; Sugrue MF
    Br J Pharmacol; 1976 Oct; 58(2):271P. PubMed ID: 974392
    [No Abstract]   [Full Text] [Related]  

  • 3. Mazindol anorexia is mediated by activation of dopaminergic mechanisms.
    Kruk ZL; Zarrindast MR
    Br J Pharmacol; 1976 Nov; 58(3):367-72. PubMed ID: 990591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some effects of mazindol, an anorectic drug, on rat brain monoaminergic systems.
    Sugrue MF; Shaw G; Charlton KG
    Eur J Pharmacol; 1977 Apr; 42(4):379-85. PubMed ID: 856614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites.
    Javitch JA; Blaustein RO; Snyder SH
    Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of brain monoamines in the anorectic activity of mazindol and d-amphetamine in the rat.
    Samanin R; Bendotti C; Bernasconi S; Borroni E; Garattini S
    Eur J Pharmacol; 1977 May; 43(2):117-24. PubMed ID: 872869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: The effect of mepiprazole on the uptake of norepinephrine, dopamine and serotonin into rat brain synaptosomes.
    Placheta P; Singer E; Krivanek W; Hertting G
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R4. PubMed ID: 1143436
    [No Abstract]   [Full Text] [Related]  

  • 8. Sertraline, 1S,4S-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthylamine, a new uptake inhibitor with selectivity for serotonin.
    Koe BK; Weissman A; Welch WM; Browne RG
    J Pharmacol Exp Ther; 1983 Sep; 226(3):686-700. PubMed ID: 6310078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the serotonergic system in the mode of action of the new potential antidepressant agent 5-methoxyindolyl-2-methylamine.
    Carranza Gómez-Carpintero MC; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Aug; 43(8):809-13. PubMed ID: 8216432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 4-(3-indolyl-alkyl) piperidine derivatives on brain 5-hydroxytryptamine turnover and on cardiac and brain noradrenaline or 5-hydroxytryptamine depletion induced by 6-hydroxydopamine, H 75/12 and 4-chloroamphetamine.
    Le Fur G; Mitrani N; Uzan A
    Biochem Pharmacol; 1977 Mar; 26(6):505-9. PubMed ID: 849347
    [No Abstract]   [Full Text] [Related]  

  • 11. The 5-hydroxytryptamine-releasing properties of two epimer quinoline derivatives.
    Le Fur G; Imbault F; Mitrani N; Marquis F; Renault C; Dubroeucq MC; Gueremy C; Uzan A
    Neuropharmacology; 1984 Feb; 23(2A):169-73. PubMed ID: 6717757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparison of fluoxetine and nisoxetine with tricyclic antidepressants in blocking the neurotoxicity of p-chloroamphetamine and 6-hydroxydopamine in the rat brain.
    Wong DT; Bymaster FP
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):221-31. PubMed ID: 981783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intraventricular injection of 6-hydroxydopamine in the developing kitten. II. On the central monoaminergic innervation.
    Bourgoin S; Adrien J; Laguzzi RF; Dolphin A; Bockaert J; Hery F; Hamon M
    Brain Res; 1979 Jan; 160(3):461-78. PubMed ID: 421125
    [No Abstract]   [Full Text] [Related]  

  • 14. A new selective inhibitor for uptake of serotonin into synaptosomes of rat brain: 3-(p-trifluoromethylphenoxy). N-methyl-3-phenylpropylamine.
    Wong DT; Bymaster FP; Horng JS; Molloy BB
    J Pharmacol Exp Ther; 1975 Jun; 193(3):804-11. PubMed ID: 1151730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine receptors on dopamine transporters are related to self-administration of cocaine.
    Ritz MC; Lamb RJ; Goldberg SR; Kuhar MJ
    Science; 1987 Sep; 237(4819):1219-23. PubMed ID: 2820058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacologic profile of fluoxetine.
    Stark P; Fuller RW; Wong DT
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):7-13. PubMed ID: 3871767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
    Wong DT; Threlkeld PG; Best KL; Bymaster FP
    J Pharmacol Exp Ther; 1982 Jul; 222(1):61-5. PubMed ID: 6123593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformationally rigid amine analogues as tools for studying the molecular requirements of uptake mechanisms.
    Tuomisto J; Tuomisto L
    Med Biol; 1974 Jun; 52(3):176-80. PubMed ID: 4423164
    [No Abstract]   [Full Text] [Related]  

  • 19. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some biochemical properties of the new potential antidepressant agent N-methyl-N-propargyl-2-(1-methyl-5-methoxyindolyl)methylamine.
    Carranza Gómez-Carpintero M; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Sep; 43(9):937-41. PubMed ID: 8240453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.